Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genta Announces Closing of $10 Million in Two Offerings of Common Stock and Convertible Notes
Yahoo/BusinessWire
Sunday, September 6, 2009 - 1:01pm
tags:
Genta
Biogen Idec offers to buy Facet for $356M
Triangle Business News
Sunday, September 6, 2009 - 1:00pm
tags:
Biogen Idec, Facet Biotech
FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA
Yahoo/PR NewsWire
Sunday, September 6, 2009 - 12:56pm
tags:
Cell Therapeutics, pixantrone
At Amgen, a Prescription for Success
Barron's
Saturday, September 5, 2009 - 12:52pm
tags:
Amgen, denosumab
Endo Pharmaceuticals launches bladder cancer drug
Trading Markets
Saturday, September 5, 2009 - 12:49pm
tags:
Endo, bladder cancer, Valstar
J&J stake in Elan could rise to 20pc after US court ruling
Independent, Ireland
Saturday, September 5, 2009 - 12:44pm
tags:
JNJ, Elan, Tysabri, Biogen Idec
Sepracor says it's staying put
Fierce Biotech
Saturday, September 5, 2009 - 12:43pm
tags:
Sepracor, M&A
Biogen Idec offers to buy Facet for $356M
Bizjournals.com
Saturday, September 5, 2009 - 12:41pm
tags:
Biogen Idec, Facet Biotech, M&A
King and Acura say FDA may not need more tests of abuse-resisting pain drug during review
Yahoo/AP
Saturday, September 5, 2009 - 12:39pm
tags:
King, FDA, Acura Pharmaceuticals, painkillers, Acurox
Big fines unlikely to steer drug companies from marketing drugs for unapproved uses
Yahoo/AP
Saturday, September 5, 2009 - 12:37pm
tags:
off-label, Pfizer, Bextra
FDA: Merck's vaccine for cervical cancer also prevents most cases of genital warts in males
Yahoo/AP
Saturday, September 5, 2009 - 12:11pm
tags:
Merck, genital wars, FDA, HPV, Gardasil
Spectrum's Zevalin OK'd for New Use
TheStreet.com
Saturday, September 5, 2009 - 12:07pm
tags:
Spectrum Pharmaceuticals, Zevalin, non-Hodgkin's lymphoma, FDA
FDA Reviewing Bristol Transplant Drug
Yahoo/AP
Friday, September 4, 2009 - 9:52am
tags:
FDA, transplant drugs, Bristol-Myers Squibb, belatacept, AstraZeneca, Eli Lilly
Hot Biotech Events for Next Week: BioBuzz
TheStreet.com
Friday, September 4, 2009 - 8:48am
tags:
biotech, Elan, Geron, Cell Therapeutics, Genta, Antigenics, Vivus, Osiris Therapeutics
Study: New, unlicensed swine flu treatment could help patients with Tamiflu-resistant viruses
Yahoo/AP
Friday, September 4, 2009 - 8:46am
tags:
Tamiflu, swine flu, H1N1, RELENZA, GSK
FDA To Review Takeda’s sNDA For Velcade
Pharmaceutical Business Review
Friday, September 4, 2009 - 7:47am
tags:
Takeda, sNDA, Velcade, FDA, Multiple Myeloma
Adeona Prepares Three Drugs for NDA Submission
Offical Wire
Friday, September 4, 2009 - 7:44am
tags:
NDA, FDA, Adeona, Trimesta, MS, Zinthionein, macular degeneration, JP1, rheumatoid arthritis
Gilead Sciences: Expect Share Price to Move Up
Seeking Alpha
Friday, September 4, 2009 - 7:42am
tags:
Gilead Sciences, antivirals
Weighing Arena's Obesity Drug: Biotech Mailbag
TheStreet.com
Friday, September 4, 2009 - 7:41am
tags:
Arena Pharmaceuticals, obesity, Biovest International, Vivus, Orexigen, Qnexa, lorcaserin
Market Curveball: Swine Flu
CNBC
Friday, September 4, 2009 - 7:40am
tags:
Sinovac, China, H1N1, vaccines, swine flu

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.